Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-03-03

FDA Approved: CAPTOPRIL — Supplemental Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for CAPTOPRIL by Camber Pharmaceuticals, granting approval of an additional generic captopril product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CAPTOPRIL (Captopril)

Snippet

SUPPL AP for CAPTOPRIL (CAPTOPRIL)